COMPLICATIONS | None N = 910 | Any* N = 154 | Any vs. None p-value | Major* N = 47 | Major vs. None p-value | Minor* N = 107 | Minor vs. None p-value |
---|---|---|---|---|---|---|---|
Hepatic Iron Staining | 152 (17%) | 31 (20%) | 0.302 | 10 (21%) | 0.412 | 21 (20%) | 0.422 |
Serum iron (ug/dL) | Â | Â | Â | Â | Â | Â | Â |
   Median [Q1, Q3] | 61 [49, 77] | 67 [54, 83] | 0.0081 | 69 [57, 83] | 0.0131 | 66 [52, 83] | 0.0971 |
   Abnormal (% > 160) | 3 (<1%) | 2 (1%) | 0.172 | 0 (0%) | 0.992 | 2 (2%) | 0.0982 |
Ferritin (ng/mL) | Â | Â | Â | Â | Â | Â | Â |
   Median [Q1, Q3] | 99 [49, 163] | 105 [62, 195] | 0.0931 | 120 [70, 235] | 0.0241 | 91 [61, 184] | 0.521 |
   Abnormal (% > 400) | 30 (4%) | 5 (4%) | 0.992 | 4 (10%) | 0.0832 | 1 (1%) | 0.242 |
Iron binding capacity (ug/dL) | Â | Â | Â | Â | Â | Â | Â |
   Median [Q1, Q3] | 316 [288, 348] | 316 [284, 352] | 0.911 | 313 [283, 348] | 0.771 | 321 [284, 353] | 0.741 |
   Abnormal (% > 428) | 21 (3%) | 3 (2%) | 0.992 | 1 (3%) | 0.992 | 2 (2%) | 0.992 |
Transferrin saturation (%) | Â | Â | Â | Â | Â | Â | Â |
   Median [Q1, Q3] | 19 [15, 25] | 21 [17, 27] | 0.0171 | 24 [19, 28] | 0.0111 | 21 [16, 27] | 0.191 |
   Abnormal (% > 55) | 0 (0%) | 3 (2%) | 0.0032 | 0 (0%) | NA | 3 (3%) | 0.00142 |